Regarding this aspect the observation that PARP12 levels inversely correlate with the survival rate of ER + breast cancer patients already treated with chemotherapy and/or hormone-based therapies is of particular interest, since it does not impinge on the survival rate of ER-negative breast cancer patients. Here, PARP12 is linked to breast cancer.